Editas Medicine Files 8-K Report
Ticker: EDIT · Form: 8-K · Filed: May 14, 2025 · CIK: 1650664
Sentiment: neutral
Topics: sec-filing, 8-k, financials
Related Tickers: EDIT
TL;DR
EDAS filed an 8-K, mostly standard stuff, check for details.
AI Summary
On May 14, 2025, Editas Medicine, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation FD disclosure. No specific financial figures or new material events were detailed in the provided text snippet.
Why It Matters
This filing indicates routine corporate reporting to the SEC, which may contain updates on financial status or other material events relevant to investors.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing header and does not contain specific material non-public information that would immediately impact risk.
Key Players & Entities
- Editas Medicine, Inc. (company) — Registrant
- 001-37687 (company) — SEC File Number
- 46-4097528 (company) — IRS Employer Identification No.
- May 14, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing by Editas Medicine, Inc.?
The filing is a Current Report pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934, reporting on Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Editas Medicine, Inc.
In which state was Editas Medicine, Inc. incorporated?
Editas Medicine, Inc. was incorporated in Delaware.
What is the principal executive office address for Editas Medicine, Inc.?
The address of the Principal Executive Offices is 11 Hurley Street, Cambridge, Massachusetts 02141.
What is the Commission File Number for Editas Medicine, Inc.?
The Commission File Number for Editas Medicine, Inc. is 001-37687.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding Editas Medicine, Inc. (EDIT).